Skip to content
Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
-$92.56M-33.6%-$88.91M-51.5%-$73.93M-42.4%-$71.13M-118%-$69.3M-75.2%
$39K-17.0%$28K-40.4%$19K-79.3%$46K-57.0%$47K-58.0%
$17.11M+94.8%$9.94M+15.9%$7.45M-40.1%$7.77M+32.2%$8.79M-39.3%
$6.53M-37.1%$1.99M-71.6%$5.92M$10.38M+189%
-$17.39M-110%$14.43M+78.0%-$8.28M-1,262%
-$672K+89.9%-$280K-162%-$6.64M-921%
$0+100%$13K+550%-$10K-433%-$1K0.0%-$2K0.0%
$197K-20.9%$271K+11.5%$263K+11.4%$257K+11.7%$249K+11.2%
-$101K+66.7%-$303K-7.6%
-$86.15M-62.5%-$76.33M-36.0%-$65.06M-137%-$54.68M-100%-$53.01M-154%
$62K$56K$0
$486.78M+316%$390.28M+462%$75.13M+528%$41.35M-79.2%$117.06M+28.3%
-$344.28M-574%-$328.39M-2,908%$50.41M$0+100%-$51.06M+44.0%
$1.12M+99.8%$11.61M+488%$808K+302%$294K-6.7%$560K+292%
$12.92M+981%$819K+422%$52K+5,100%$23K+76.9%$1.2M+772%
$609.43M+1,023%$612.52M+438%$6.76M+370%$28.63M-86.8%$54.27M-70.3%
$179M+459%$207.8M+345%-$7.89M-134%-$8.15M-$49.81M-170%
$655K-46.7%$671K-51.7%$705K-64.8%$987K-35.5%$1.23M+1,363%
$39K-17.0%$28K-40.4%$19K-79.3%$46K-57.0%$47K-58.0%
-$101K+66.7%-$303K-7.6%
-$672K+89.9%-$280K-162%-$6.64M-921%
$197K-20.9%$271K+11.5%$263K+11.4%$257K+11.7%$249K+11.2%
$1.75K$1.75K$1.75K$1.75K
$0-100%$64K
$4.09M$0
$1.43M$0
-$86.21M-62.6%-$76.33M-36.0%-$65.06M-137%-$54.73M-101%-$53.01M-154%
-$86.21M-62.6%-$76.33M-36.0%-$65.06M-137%-$54.73M-101%-$53.01M-154%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Praxis Precision Medicines, Inc. generate?
Praxis Precision Medicines, Inc. (PRAX) generated -$282.2M in operating cash flow over the trailing twelve months.
What is Praxis Precision Medicines, Inc.'s free cash flow?
After $118.0K of capital expenditures, Praxis Precision Medicines, Inc.'s free cash flow was -$282.3M over the trailing twelve months, down 72.3% year over year.
Where does Praxis Precision Medicines, Inc.'s cash flow data come from?
Every line is extracted from Praxis Precision Medicines, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.